Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
04/16/14 Baxter (BAX) BAX 111 for Von Willebrand Disease Subscribers Only Subscribers Only     Subscribers Only
04/16/14 Spectrum (SPPI) Belinostat (Oral) for Solid Tumors Subscribers Only Subscribers Only     Subscribers Only
04/16/14 Mallinckrodt (MNK) Exalgo for Arthritis Pain Subscribers Only Subscribers Only     Subscribers Only
04/15/14 GlaxoSmithKline (GSK) Tanzeum for Diabetes Mellitus, Type II Subscribers Only Subscribers Only     Subscribers Only
04/14/14 Lexicon Pharmaceuticals (LXRX) LX4211 for Diabetes Mellitus, Type I Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement